Arthur A. Levin, Director: Stoke Therapeutics STOK Sell · Filed 03/17

Trade details

Type: Insider sale
Amount: $22,264
Shares · price: 605 sh · $36.80 a share
Held after: 4,237 sh
Stock: Stoke Therapeutics STOK
Person: Arthur A. LevinDirector
Trade date: 26/03/13
Filed: 26/03/17
Days to filing: 4 days

Sold 12.5% of holdings

Share of holding sold: 12.5%

Stoke Therapeutics trades, last 26 weeks

What else happened in Stoke Therapeutics around then

Filed or reported within 30 days of the trade day · 02/11~04/12

Arthur A. Levin's recent trades

Arthur A. LevinDirector
Planned sale10b5-1 planStoke Therapeutics
Planned sale10b5-1 plan
Stoke Therapeutics
STOK
$22.1K
605 sh
$22.1K
Filed 03/13
Traded 03/13
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$127.4K
1,758 sh
$127.4K
Filed 01/23
Traded 01/21
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$5.1M
107,500 sh
$5.1M
Filed 25/08/08
Traded 25/08/06
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$53.5K
1,872 sh
$53.5K
Filed 25/01/23
Traded 25/01/21
Arthur A. LevinDirector
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$140K
3,323 sh
$140K
Filed 24/11/20
Traded 24/11/19